Beam Therapeutics shareholders elect Graham Cooper as Class I director, ratify auditor, approve say-on-pay

Beam Therapeutics Inc.

Graham Cooper elected to board with 49.5M for, 6.5M against, 1.8M abstain, 8.4M broker non-votes.
Deloitte & Touche ratified as auditor for FY2024: 66.0M for, 176k against, 42k abstain.
Advisory vote on executive compensation passed: 56.5M for, 1.3M against, 45k abstain, 8.4M broker non-votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.